Home
About
Overview
Sharing Data
ORCID
Help
History (63)
Effects of obesity and race on prognosis in lymph node-negative, estrogen receptor-negative breast cancer.
Early stopping of a clinical trial when there is evidence of no treatment benefit: protocol B-14 of the National Surgical Adjuvant Breast and Bowel Project.
Hazard of recurrence and adjuvant treatment effects over time in lymph node-negative breast cancer.
DTNBP1 (Dystrobrevin binding protein 1) and schizophrenia: association evidence in the 3' end of the gene.
Efficacy of systemic adjuvant therapy for breast cancer in African-American and Caucasian women.
See All 63 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Efficacy of systemic adjuvant therapy for breast cancer in African-American and Caucasian women.
Efficacy of systemic adjuvant therapy for breast cancer in African-American and Caucasian women. J Natl Cancer Inst Monogr. 2001; (30):36-43.
View in:
PubMed
subject areas
Aged
Antineoplastic Agents
Breast Neoplasms
Chemotherapy, Adjuvant
Disease-Free Survival
Female
Humans
Lymphatic Metastasis
Middle Aged
Odds Ratio
Randomized Controlled Trials as Topic
Receptors, Estrogen
Survival Rate
authors with profiles
James Dignam